A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Antonio Carlo BossiFranco ForloniPaolo L ColombelliPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)